What to Do If You Have Lupus and Discover an Unexpected Pregnancy
Understanding the Risks and Making Informed Decisions
Discovering an unexpected pregnancy while managing systemic lupus erythematosus (SLE) can be both emotionally overwhelming and medically complex. However, with timely evaluation, expert multidisciplinary care, and evidence-based guidance, many individuals with well-controlled lupus go on to have healthy pregnancies and babies. The key lies in assessing disease activity, reviewing current medications, and collaborating closely with specialists.
When Lupus Is Well-Controlled: A Favorable Outlook
If your SLE has been in stable clinical remission for at least six months—with minimal or no active symptoms, normal lab markers (e.g., low anti-dsDNA titers, stable complement levels), and no recent flares—you're generally considered a strong candidate for continuing the pregnancy. In such cases, medications like hydroxychloroquine (HCQ) and azathioprine are not only safe but strongly recommended throughout gestation. HCQ, in particular, significantly reduces flare risk and improves maternal and fetal outcomes.
Medication Safety Matters—Here's What to Know
Not all immunosuppressants are pregnancy-friendly. While azathioprine and low-dose corticosteroids pose minimal risk, others—including mycophenolate mofetil, methotrexate, cyclophosphamide, and leflunomide—are strictly contraindicated due to proven teratogenicity and potential fetal harm. If you've recently taken any of these drugs, your rheumatologist and maternal-fetal medicine specialist will assess timing, drug clearance, and fetal ultrasound findings to determine individualized risk and monitoring strategies.
Active Disease or Organ Involvement: Prioritizing Maternal and Fetal Safety
Pregnancy during active lupus—especially with kidney involvement (lupus nephritis), central nervous system manifestations, or significant hematologic or pulmonary disease—carries substantially higher risks. Flares may worsen rapidly, increasing chances of preeclampsia, preterm birth, intrauterine growth restriction (IUGR), or even maternal mortality. In these scenarios, shared decision-making becomes critical: your care team will discuss realistic outcomes, available interventions, and whether continuing the pregnancy aligns with your overall health goals and values.
Special Considerations: Anti-Ro/SSA and Anti-La/SSB Antibodies
If you test positive for anti-Ro (SSA) or anti-La (SSB) antibodies—a common finding in lupus—your baby is at increased risk for neonatal lupus syndrome, particularly congenital heart block. Starting at 16 weeks' gestation, regular fetal echocardiograms are recommended every 1–2 weeks through week 26 to monitor for early conduction abnormalities. Early detection allows for prompt intervention, including possible maternal treatment with fluorinated corticosteroids if signs of inflammation appear.
Your Care Team Is Your Greatest Ally
Navigating an unplanned pregnancy with lupus requires seamless coordination between rheumatology, maternal-fetal medicine (MFM), nephrology (if needed), and cardiology. A formal joint consultation ensures comprehensive evaluation—not just of disease status and meds, but also of psychosocial support, nutrition, vaccination status (e.g., flu and Tdap), and long-term postpartum planning. Don't hesitate to ask about fertility preservation options before future pregnancies, or explore lactation-safe medication regimens ahead of time.
Bottom Line: Hope, Guidance, and Personalized Care
An unexpected pregnancy doesn't mean compromising your health—or your dreams of parenthood. With modern lupus management, proactive monitoring, and a trusted care team, many people thrive before, during, and after pregnancy. The most important first step? Schedule an urgent appointment with your rheumatologist and OB-GYN—ideally one experienced in high-risk pregnancies. From there, you'll receive tailored advice rooted in science, compassion, and real-world experience.